Oncology

The drug neratinib (HKI-272, Nerlynx®) was originally developed by Wyeth Research Laboratories, with its initial characterisation published in 2004…

In the era of target and immunotherapy, the multidisciplinary approach of lung cancer is now mandatory. Close collaboration between pulmonologists…

Accessory breast is a congenital atavism condition. Accessory breast tissue may arise anywhere along the mammary line because of the failure of complete…

Ibuprofen belongs to the group of nonsteroidal anti-inflammatory drugs (NSAID) used to treat diverse inflammatory processes, pain, or fever…

Cardiac tumours are rare, with their incidence estimated between 0.0017–0.2800%,1 and the vast majority are metastatic lesions…

There is a connection between increased body mass, or adipose tissue, and higher risk of developing cancer, particularly in hormone-stimulated neoplastic…

Over 70% of patients with early-stage breast cancer are diagnosed with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative…

There has been a decrease in the number of incidences of lung cancer recorded among men over the past few decades as well as among women…